The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynairgen Share News (SNG)

Share Price Information for Synairgen (SNG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.20
Bid: 5.52
Ask: 7.00
Change: 0.00 (0.00%)
Spread: 1.48 (26.812%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 6.20
SNG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: Mining stocks pull FTSE 100 lower ahead of data

Thu, 12th Jun 2014 08:25

- Profit taking continues as miners fall- Traders await global economic data- Broker downgrades hit blue chipstechMARK 2,839.63 -0.04%FTSE 100 6,827.09 -0.17%FTSE 250 16,073.58 -0.09%UK stocks opened flat on Thursday morning as weakness in the mining sector held back any chances of a rebound.After coming within reach of a 14-year closing high earlier in the week, the FTSE 100 suffered a steep fall on Wednesday to finish at 6,838.87. Investors were looking to book profits with global equity indices trading at multi-year or record highs, while sentiment was dampened further after the World Bank downgraded its growth forecasts.Subdued risk appetite was keeping investors from 'buying on the dip' this morning as they awaited what is set to be a somewhat heavier session in terms of macro data. The FTSE 100 was 0.2% lower at 6,827 in early trading.Mike van Dulken, Head of Research at Accendo Markets, said that after the recent run on major bourses, traders are now "concerned about complacency and the emergence of fresh risks following a period of relative calm". Nevertheless, the FTSE 100 still remains range-bound with "catalysts lacking (for now) for a break either way", he said.After a quiet start to the week on the economic calendar, the focus today will turn to Eurozone industrial production, French inflation and US retail sales and jobless claims figures.Mining stocks fallMiners were among the worst performers this morning with Anglo American, BHP Billiton, Rio Tinto and Antofagasta falling sharply. Anglo was cut from 'equal weight' to 'underweight' at Morgan Stanley today.Shares in AstraZeneca rose after the pharmaceutical group signed a licence agreement with AIM-listed Synairgen for the development of SNG000l, a treatment for respiratory tract viral infections in patients with severe asthma.Natural gas producer BG Group was lower as it suffered from a ratings downgrade by Nomura to 'neutral'. Publisher Pearson was subdued after a Goldman Sachs downgrade to 'sell', while temporary power and temperature control group Aggreko was hit with a downgrade to 'sector performer' by RBC Capital Markets.In contrast, Provident Financial was on the rise after Citigroup lifted its recommendation on the stock to 'buy' and hiked its target price by nearly 38%.Infrastructure and construction peers Balfour Beatty, Galliford Try and Carillion all fell despite the news that they have been appointed as preferred bidders to work on a £745m project to build new roads in Scotland.Halma impressed with record annual revenue as the safety, health and environmental technology group achieved growth across all its sectors.Home improvement retailer Kingfisher edged lower after revealing that Philippe Tible, Chief Executive of its European Castorama & Brico Depot brands, will step down from the board at the end of July.FTSE 100 - RisersITV (ITV) 179.60p +1.70%Unilever (ULVR) 2,700.00p +0.82%AstraZeneca (AZN) 4,434.00p +0.77%British American Tobacco (BATS) 3,564.00p +0.59%Reckitt Benckiser Group (RB.) 5,155.00p +0.59%Lloyds Banking Group (LLOY) 79.51p +0.57%Imperial Tobacco Group (IMT) 2,640.00p +0.46%Diageo (DGE) 1,915.50p +0.45%Rolls-Royce Holdings (RR.) 1,021.00p +0.39%GlaxoSmithKline (GSK) 1,617.50p +0.37%FTSE 100 - FallersAnglo American (AAL) 1,410.50p -3.69%Rio Tinto (RIO) 3,093.00p -2.01%BHP Billiton (BLT) 1,856.50p -1.90%Aggreko (AGK) 1,628.00p -1.75%Sainsbury (J) (SBRY) 327.90p -1.53%International Consolidated Airlines Group SA (CDI) (IAG) 394.10p -1.48%Antofagasta (ANTO) 760.00p -1.23%Fresnillo (FRES) 783.50p -1.14%Glencore (GLEN) 320.60p -1.11%ARM Holdings (ARM) 898.00p -1.05%FTSE 250 - RisersOcado Group (OCDO) 380.00p +3.43%Provident Financial (PFG) 2,221.00p +2.26%Halma (HLMA) 602.50p +1.95%Partnership Assurance Group (PA.) 132.20p +1.85%Premier Farnell (PFL) 212.20p +1.82%Perform Group (PER) 274.50p +1.63%Fisher (James) & Sons (FSJ) 1,330.00p +1.53%Alent (ALNT) 335.00p +1.52%PayPoint (PAY) 1,131.00p +1.25%Infinis Energy (INFI) 211.60p +1.24%FTSE 250 - FallersAfren (AFR) 140.90p -2.29%Lonmin (LMI) 232.40p -1.82%Synthomer (SYNT) 244.97p -1.81%African Barrick Gold (ABG) 219.30p -1.75%Polymetal International (POLY) 545.50p -1.71%Evraz (EVR) 97.90p -1.66%Victrex plc (VCT) 1,737.00p -1.64%Ophir Energy (OPHR) 237.00p -1.62%Serco Group (SRP) 364.80p -1.33%Aveva Group (AVV) 2,217.00p -1.25%BC
More News
28 May 2020 14:49

UK TRADING UPDATE SUMMARY: PureTech, N4, Synairgen Advance Covid Work

UK TRADING UPDATE SUMMARY: PureTech, N4, Synairgen Advance Covid Work

Read more
26 May 2020 13:55

Synairgen Loss Widens; Progressing On SNG001 Study For Covid-19

Synairgen Loss Widens; Progressing On SNG001 Study For Covid-19

Read more
31 Mar 2020 12:21

UK TRADING UPDATE SUMMARY: Synairgen Starts Covid-19 Treatment Trial

UK TRADING UPDATE SUMMARY: Synairgen Starts Covid-19 Treatment Trial

Read more
29 Mar 2020 21:00

Sunday share tips: Synairgen, Hollywood Bowl

(Sharecast News) - The Sunday Times's Sabah Meddings recommends buying shares of Synairgen arguing that the Covid-19 pandemic may have given the firm a new lease on life.

Read more
29 Mar 2020 20:57

Sunday newspaper round-up: Restrictions, Unemployment, Blood plasma

(Sharecast News) - "Life in Britain will not return to normal for six months, England's deputy chief medical officer has warned, as ministers begin preparing the public for an extended period of lockdown. At the government's daily press conference, Jenny Harries said that strict social distancing rules may have to be in place for between two and three months. But she added that it would be a further three months before all restrictions were lifted, and even then there were likely to be "bumps" as new clusters of cases of coronavirus were identified." - Sunday Times

Read more
26 Mar 2020 14:26

UPDATE: Synairgen Successfully Raises Cash For Covid-19 Trials

UPDATE: Synairgen Successfully Raises Cash For Covid-19 Trials

Read more
26 Mar 2020 06:58

Synairgen Raises Cash To Go Towards Covid-19 Drug Trial

Synairgen Raises Cash To Go Towards Covid-19 Drug Trial

Read more
18 Mar 2020 18:42

Britain's Synairgen gets green light for coronavirus drug trial

By Paul SandleLONDON, March 18 (Reuters) - British pharmaceutical company Synairgen said on Wednesday it had the go-ahead to test a drug that could boost the lung function of patients with coronavirus, potentially assisting in the global fight aga...

Read more
18 Mar 2020 16:59

Synairgen Gets Expedited UK Approval To Trial SNG001 For Covid-19

Synairgen Gets Expedited UK Approval To Trial SNG001 For Covid-19

Read more
18 Mar 2020 11:17

Synairgen to begin trial of potential Covid-19 therapy

(Sharecast News) - Respiratory drug discovery company Synairgen has received expedited approvals from the Medicines and Healthcare Products Regulatory Agency (MHRA) and Health Research Authority (HRA) to conduct a trial of 'SNG001', an inhaled formulation of interferon-beta-1a, in Covid-19 coronavirus patients, to potentially assist with the global virus pandemic.

Read more
1 Oct 2019 13:42

Synairgen Interim Loss Deepens On Costs As Progresses Clinical Trials

Synairgen Interim Loss Deepens On Costs As Progresses Clinical Trials

Read more
27 Sep 2019 13:32

Synairgen Expects Positive Outcome From Second Part Of SNG001 Study

Synairgen Expects Positive Outcome From Second Part Of SNG001 Study

Read more
24 Jul 2019 12:58

Synairgen Encouraged By Findings So Far In Interferon Beta COPD Study

(Alliance News) - Synairgen PLC on Wednesday said a phase two trial in its inhaled interferon beta programme has found cold and flu infections worsen symptoms for chronic obstructive pulmonary in

Read more
9 Jul 2019 09:26

CORRECT (Jul 8): Woodford Transfers Company Stakes After Omnis Departs

(Correcting that Woodford Investment Management transferred a number of stakes following Omnis's decision. It did not sell these stakes, as was originally reported.)(Alliance News) - of

Read more
18 Apr 2019 11:52

Synairgen Non-Executive Director Paul Clegg To Retire In June

LONDON (Alliance News) - Synairgen PLC on Thursday said Non-Executive Director Paul Clegg will retire from the company's board after the company's annual general meeting on June Buchanan,

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.